GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

136 hedge funds and large institutions have $338M invested in Sanofi Contingent Value Rights in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

Holders
136
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.01M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.13M
2
+$6.35M
3
+$2.39M
4
DI
Dalton Investments
Nevada
+$1.31M
5
SC
Sophrosyne Capital
New York
+$1.16M

Top Sellers

1
-$5.79M
2
-$3.55M
3
-$2.51M
4
BlackRock
BlackRock
New York
-$2.4M
5
PCM
Pentwater Capital Management
Florida
-$1.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.5M
27
$2.43M
28
$2.06M
29
$1.88M
30
$1.87M
31
$1.86M
32
$1.8M
33
$1.77M
34
$1.62M
35
$1.45M
36
$1.25M
37
$1.16M
38
$1.1M
39
$1.04M
40
$1.01M
41
$976K
42
$960K
43
$525K
44
$444K
45
$440K
46
$367K
47
$309K
48
$306K
49
$303K
50
$303K
1
2
3 4 5